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Translating Research:
ICTS Business Development Core
Exploring research questions and potential inventions, commercializing research discoveries and
evaluating community benefits are three aspects of translation that are supported through various
ICTS programs. To uncover commercial opportunities and promote investigator awareness, the
ICTS offers the services of the Business Development Core (BDC). The BDC is an important contributor with a core objective of actively pursuing industrial relations for the translation and commercialization of ICTS funded and ICTS member-developed technologies. The BDC is integrated
into the Washington University Office of Technology Management (OTM). Co-Directors Bradley
J. Castanho, PhD and Michael T. Marrah, JD have cultivated relationships with business leaders
in the St. Louis community to better understand how to work more effectively in the transfer and
licensing of intellectual property (IP) from WU to private companies to promote translation of
research to the community.
A key aim of the BDC is to identify the clinical and translational research projects that have significant potential to lead to diagnosis or treatment of disease at an early stage, and to provide the
necessary expertise and administrative support to realize this potential through commercialization. To achieve this aim the BDC is proactive by offering educational opportunities to the faculty
on how to manage IP opportunities and contacting individual investigators to discuss commercial
potential of their projects. In addition, the BDC serves as a matchmaker between investigators and
industrial partners.
Toward this goal of being proactive, three fellowships were recently established in BDC under an
award received by the WU Skandalaris Center. These fellows contact faculty to discuss projects
and the importance of, not only protecting the IP from their research, but also the subsequent
translation work of that IP into commercial licenses. This effort is funded in part by a National
Science Foundation grant and is coordinated with local St. Louis community incubators – i.e. Biogenerator, Angel Network, Nidus Center and Center for Emerging Technologies. The BDC staff is
also available to provide educational sessions at department or center meetings.
(See Translating Research: page 2)

Message from the Director: Kenneth S. Polonsky, MD.
During the last 20 months since the CTSA grant was funded, more than 650 investigators have become
members of the ICTS. Those members have benefited in a variety of ways. The ICTS has awarded over $2.4
million to members through the three ICTS funding programs. During our 02 year of funding, 386 investigators received services from the ICTS Cores and those investigators were associated with 185 NIH grants that
benefited from the services. In our recently submitted annual progress report we also noted over 1350 services
that were delivered by ICTS Cores during the Institute’s second year.
The ICTS infrastructure was designed to provide needed resources and expertise for the various phases of
clinical and translational research projects. The ICTS Tracking and Evaluation Group, in collaboration with
the Siteman Cancer Center (SCC) administration, recently issued a User Satisfaction Survey to ICTS and SCC
members to help us gauge where we are succeeding in meeting member needs and what areas still need attention. We received responses from 203 members and are currently evaluating those responses. As we move
into our third year of funding, we will continue to work toward enhancing service delivery as well as turning
attention to longer term initiatives. For example, ICTS Program Directors submitted 8 CTSA administrative
supplement proposals to the NCRR for funds made available under the American Recovery and Reinvestment
Act. If these applications are successful, not only will it strengthen collaborations with some of our CTSA
cohorts, but also further our translational initiatives locally. Despite the current economic challenges, I am
increasingly encouraged by the opportunities for innovative, collaborative research programs that the ICTS
creates.
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Translating Research, from Page 1
ICTS Pilot Application Commercial Potential
The BDC/OTM Fellows specifically play a role in
evaluating the commercial potential of the projects
submitted to the ICTS pilot funding program. The
Fellows met with each of the investigators of the 15
funded proposals from the 2008 ICTS Pilot and Novel
Methodologies Funding Program to evaluate each
project for its potential commercial opportunity. Such
meetings will also be conducted with the investigators
of the 2009 ICTS funded pilot projects. In addition,
even if not chosen for funding through the BJHF/ICTS
pilot program, if the proposed project was flagged by
either the applicant or reviewer as having commercial
potential, the BDC will contact the investigator. The
Principal Investigator is interviewed to provide BDC
staff with a better understanding of the project and
promote investigator awareness of the nuances related
to commercialization opportunities such as licensing,
copyright and patents. For the first round, investigators of 40 unfunded projects were contacted and 18
meetings were held with investigators to evaluate options and build awareness.

New Quick-Material Transfer Agreements (MTA) and
National CTSA Consortium Influence
Material Transfer Agreements have become increasingly onerous barriers to the free and open exchange
of scientific information and materials. The new WU
Quick-MTA tool has been developed by OTM in an
effort to simplify the process of sending basic research
tools from Washington University to other academic
and non-profit researchers. In addition, Dr. Castanho
sits on the national CTSA Public and Private Partnership (PPP) Key Function Committee and has been able
to influence some of the 39 other CTSA institutions
to adopt this specific tool or adopt similar less onerous processes. The new WU Quick-MTA form and
instructions will soon be available on the OTM website
and in the meantime can be obtained by emailing
mta@otm.wustl.edu.
For additional information about the Business Development
Core services refer to the ICTS website (http://icts.wustl.edu/
cores/bdc.aspx) or contact Brad Castanho at 747-0927 or
bjcastanho@wustl.edu.

CTSA Pharmaceutical Assets Portal Survey
The National Center for Research Resources (NCRR) has funded a pilot project to build a portal that would match academic researcher needs for investigational compounds with pharmaceutical assets for research and clinical treatment.
To lay the foundation for this portal, the study partners are asking all CTSA researchers to take a survey that will:
•

Identify whether discontinued investigational compounds are available for your research;

•

Identify potential researchers for collaboration and form clusters of expertise for future multi-disciplinary and
multi-institutional investigations.

		

Take the survey at: www.ctsapharmaportal.org

The information you provide will contribute to a better understanding of industry barriers such as transferring or inlicensing of compounds. The larger Portal Project hopes to forge relationships between researchers and pharmaceutical companies to provide access to assets and request compounds directly from companies. Translational researchers
would gain access to drugs with an established safety profile that may benefit approval of licensing for new indications
or for commercial use.

In the News
Three ICTS members -- Drs. Randall J. Batemen, David M. Holtzman, and John C. Morris -- participated in HBO’s The Alzheimer’s Project. This multi-platform media series examines recent research about Alzheimer’s by our country’s leading scientists, including those working through the Alzheimer’s Disease Research Center at Washington University. The entire project
includes four documentaries, 15 supplemental films, an extensive resource website, and a nation-wide community outreach
campaign. All the films can be viewed at http://www.hbo.com/alzheimers/. The project is a partnership between HBO Documentary Films and the National Institute on Aging of the National Institutes of Health in association with the Alzheimer’s
Association®, Fidelity® Charitable Gift Fund, and Geoffrey Beene Gives Back® Alzheimer’s Initiative.
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Reporting Back to the Community: Center for Community Based Research
The activities of the Center for Community Based Research (CCBR) are
part of Washington University’s ongoing
effort, through its Clinical and Translational Sciences Award and the ICTS,
to increase the relevance of research
to community needs, further expand
community participation, and disseminate more research findings back to the
community.
The CCBR and the Siteman Cancer
Center’s Program for the Elimination of
Cancer Disparities (PECaD), in partnership with the St. Louis American
Foundation, hosted a poster session during a reception held before the St. Louis
American Foundation’s Annual “Salute
to Excellence in Healthcare” Luncheon.
The event was held April 25, 2009 at the
Hilton St. Louis at the Ballpark.
“The poster session provided a unique
opportunity for those who attended the
Salute to become more knowledgeable
about some of the promising research
that is conducted locally. The information was especially relevant to our community and the presentation was

The posters reported on a range of topics including sickle cell disease, obesity,
STDs and more. “We wanted to share
with community members and providers the findings of the research being
conducted that impacts them and their
surrounding community,” says Victoria
Anwuri, MPH, PECaD Project Manager
and Salute awardee.

Photo courtesy of CCBR
well-received and enhanced the learning experience for our attendees.” says
Donald M. Suggs, President, St. Louis
American Foundation. Ten posters
were selected by a formal community
and academic review process based on
their relevance to community needs and
interests from posters originally presented at the opening event launching
the Washington University Institute for
Public Health.

Guests provided positive feedback
about the posters and indicated that they
would like to see them again in other
venues. “Feedback from the exhibit
will help us find better ways to deliver
on the promise of research: to improve
the health and wellness of all people,”
says Dr. Katherine Mathews, CCBR
Co-Director. “In the future, we hope to
expand the exhibit to new locations and
include additional research projects that
can benefit the St. Louis community.
Through this project and other similar initiatives, we hope to continue an
important dialogue with the community
about how research can best benefit the
community at large.”

Business Development Advisory Committee Meets
The Business Development Advisory Committee
(BDAC), working with the ICTS Business Development Core, is chaired by John McDonnell, Chairman of
the Board of BioGenerator and Vice-Chairman of the
Washington University Board of Trustees. The BDAC
met on April 20th and was attended by representatives
from 7 St. Louis companies, Saint Louis University, and
Washington University.
Kenneth S. Polonsky, MD, Director of the ICTS provided a general overview of the ICTS activities, including a description of current funding programs and the
Center for Biomedical Informatics initiatives. Bradley
J. Castanho, PhD, Co-Director of the BDC, described
three initiatives of the BDC:
•

•

Interactions with the CTSA Public & Private
Partnership (PPP) initiative: The PPP is a committee consisting of representatives from the 39
CTSA organizations focused on streamlining the
process for developing public/private partnerships.
Bear Cub Fund: This WU funding program is
made up of endowment income and capital from
private sources and is designed to promote commercialization of local research discoveries.

•

FastTrac Training: This entrepreneurial training is
sponsored by the Kauffman Institute and is made
available to invited faculty with interest in exploring the possibility of starting a company based on
their research discoveries.

The committee agreed on some initiatives to explore
during the next year, including fund raising opportunities and ways to leverage local business efforts in
promoting translation of research into commercial
practice.

Just In Time (JIT) Core Usage
Funding Program
The maximum amount for JIT Core Usage awards is now
$5,000.
In the case of requesting services from the Human Imaging
Unit, the maximum allowable request is $10,000 due to the
availability of matching funds from the WU Mallinckrodt
Institute of Radiology (MIR).
For more information visit the ICTS website page:
http://icts.wustl.edu/funding/jit_core_usage_funding_program.aspx
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Subject Enrollment
Reporting is Key
			
By Charles Rathmann
Recruitment of potential participants into clinical trials at Washington University continues to be a major
challenge for investigators and research coordinators
tasked with the execution of these trials. Fortunately,
the ICTS has two groups dedicated to helping study
teams meet and even exceed their recruitment and
enrollment targets:
•

The Recruitment Enhancement Core (REC) in the
Regulatory Support Center, which includes the Research Participant Registry, powered by Volunteer
for Health, and

•

The Center for Community Based Research
(CCBR) which connects underrepresented volunteers to clinical research through a community
based site called HealthStreet, as well as a community outreach van.

When recruitment services are requested, the REC and
the CCBR provide referrals of potential participants
who are interested in and who may qualify for the clinical trials. Most referrals are even prescreened against
the inclusion and exclusion criteria of those trials.
In order for the REC and the CCBR to measure the
impact they have on enrollment for trials they support,
as well as the impact on the overall vision of the ICTS,
it is imperative that they track the referrals they send to
study teams. Both ICTS cores send inquiries by e-mail
and call to find out if the potential participants were
enrolled, randomized, screen failed, not qualified, etc.
The feedback provided about the referrals is critical for
the REC and the CCBR to evaluate what strategies lead
to maximizing enrollment and what strategies need
to be adjusted. It cannot be emphasized enough how
important this information is so that study enrollment yield can be measured in order to improve core
services to meet the needs and expectations of the
investigators and the participants.
PLEASE DO YOUR BEST TO RESPOND TO
REQUESTS AND ACCURATELY REPORT THE
ENROLLMENT INFORMATION THAT IS BEING
REQUESTED BY THE REC and CCBR.
If you have any questions or comments, please contact
Charles Rathmann, Director of the REC, at 314-3620897 or rathmannc@wusm.wustl.edu or Dr. Linda
Cottler at HealthStreet at 314-531-3034 or ctsa@epi.
wustl.edu.

Have You Met?
Michelle Jenkerson, RN, RRT, CCRC, a graduate

of the Barnes-Jewish College
of Nursing and the Cardinal
Glennon Respiratory Therapy
School, is the Research Participant Advocate (RPA) for
the ICTS Regulatory Support
Center (RSC). Upon graduation, Michelle along with a
therapist and a pilot, formed
a transport response team
that traveled by ambulance,
helicopter, or jet to transport pediatric patients to
Cardinal Glennon for care. “I learned a lot of life lessons during those 13 years. Most importantly life is
too short and precious to sweat the small stuff.”
After her response team experience, Michelle worked
in the Pulmonary Department at The Jewish Hospital
of St. Louis for 6 years and became a Washington
University (WU) employee when that department
was merged into the WU Pulmonary Lab. She served
as a nurse/respiratory therapist for Dr. Mario Castro,
Professor of Medicine, until 2001 when she took the
job as the Research Participant Advocate in the WU
General Clinical Research Center (GCRC). The RPA
position was required under the GCRC and Washington University has maintained this activity under the
Institute of Clinical and Translational Sciences.
As the Research Participant Advocate, Michelle
reviews research protocols and consent forms that request CARS resources. She also interviews a randomized subset of subject participants and is responsible
for ensuring participant rights are safeguarded on any
of the CARS units.
A Certified Clinical Research Coordinator (CCRC)
herself, Michelle is concerned about improving
training and educational opportunities for research
coordinators and is actively involved in the WU
Research Education Task Force. She believes that
up-front training, as opposed to the “learn by doing”
technique, enhances compliance, and allows the
coordinator to develop expertise and confidence,
preventing problems in the long run. She has worked
with Sally Anderson, RN, BSN, CCRC, Director of
the CARS Clinical Research Services, to develop an
extensive training and orientation program for CARS
research coordinators and has shared lessons learned
with a national audience at the Association of Clinical
See Have you Met?: page 5
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Past Events & Updates

Events & Announcements

April 20: Business Development Core: The Business
Development Advisory Committee met. (See article
on page 3 for details.)

June 25 (Noon-1:00 pm): Center for Applied Research
Sciences: Brown Bag Seminar, Holden Auditorium, Farrell Learning and Teaching Center. Speakers include:

April 26: Center for Applied Research Sciences:
The Association of Clinical Research Professionals
(ACRP) held the ACRP 2009 Global Conference in
Denver, Colorado. Sally Anderson, RN, BSN, CCRC,
Director of Clinical Research Services at the ICTS
CARS and Michelle Jenkerson, Research Subject Advocate for CARS presented a talk entitled “Creation and
Implementation of a Clinical Research Coordinator
Education and Mentoring Program.”

•

Rakesh Nagarajan, MD, PhD, Center for Biomedical
Informatics (CBMI)

•

Ken Schechtman, PhD, Research Design & Biostatistics Group (RDBG).

May 4 and 5: Clinical Research Training Center:
2009 National Predoctoral Clinical Research Training
Conference. Washington University School of Medicine hosted the first national meeting convened for
students and faculty involved in NIH-sponsored predoctoral clinical research training programs. The event
was held at the Eric P. Newman Education Center. For
complete conference information visit
http://t32.im.wustl.edu/predocnational/index.html.
The conference was sponsored by WU School of
Medicine, Barnes-Jewish Foundation, The National
Institutes of Health, and the ICTS.
May 19: Center for Applied Research Sciences:
The Brown Bag Seminar Series, “Public Relations and
Marketing Services for Your Research Studies,” was
presented by WU Medical Public Affairs staff Joni
Westerhouse, Executive Director for Medical Communications, and Donna De Pond, Executive Director,
Creative Services and Marketing.

June 26 (8:00 am-Noon): ICTS Clinical Research
Training Center: The CRTC will host the 3rd Annual
Career Development Retreat, Moore Auditorium.
•

8:30 – 9:30 am -- “Exciting Careers in Clinical
and Translational Research: the Perspective of
a Department Head,” Kenneth S. Polonsky, MD,
Aldolphus Busch Professor and Chairman, Department of Medicine, Director, ICTS

•

9:45 – 10:45 am -- “A Career Studying Sex: Follow Your Passion in Academic Medicine,” Jeffrey
F. Peipert, MD, PhD, Robert J. Terry Professor and
Vice Chair of Research, Department of Obstetrics
and Gynecology

•

11:00 am – Noon -- “Effective Presentations,”
Thomas M. De Fer, MD, FACP, Associate Professor
of Medicine, Director, Internal Medicine Clerkship
and the ACES Program

RSVP by June 19 : 314-454-8244; mfavazza@dom.wustl.edu

July 14-15: NCRR Workshop: Efficient Management
and Utilization of Core Facilities. Natcher Center, NIH
Campus, Bethesda, MD This workshop will examine
the state of existing NIH-funded research core facilities,
identify common problems encountered, and discuss solutions to maximize their use. For more information or
to register, visit http://www.ncrr.nih.gov/Core_Facilities.

Have You Met, from Page 4
Research Professionals (ACRP) Global conference in Colorado in April, 2009. She also teaches the Fundamentals of
Clinical Research Management Courses I and II as part of the
University’s Clinical Management Certificate and Bachelors
Degree programs.
Michelle’s husband, Dennis Jenkerson, has been Chief of
the St. Louis Fire Department since November, 2007 and is
a third generation firefighter. Having met in kindergarten,
they started dating in high school and were married after
college graduation. Their daughter, Danielle was married
last October and works in public relations and marketing.
Their daughter Emily works with the WU Volunteer for
Health, and their son, Denny, is a senior at the University of
Missouri, Columbia.

Michelle is gracious and well suited to represent Washington
University in her interactions with study participants and
the City of St. Louis in community events with her husband. With grandparents that immigrated to St. Louis from
Italy and a father that served as St. Louis City Assessor for
St. Louis, Michelle states, “I’ve always lived in the city, was
educated here and have never had a job outside the city limits.” Seems it would be difficult to be more closely connected
to St. Louis than that.
For more information about Research Participant Advocacy
or clinical research coordinator training opportunities, contact Michelle at jenkerson_m@gcrc.wustl.edu or 314-3625626.

Campus Box 8066, 660 S. Euclid Ave. , St. Louis, MO 63110 Phone: (314) 362-9829 Email: icts@wustl.edu Web: icts.wustl.edu
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